EMA — authorised 27 May 2011
- Application: EMEA/H/C/002104
- Marketing authorisation holder: Novartis
- Local brand name: Joicela
- Status: withdrawn
🇪🇺 Joicela in European Union
EMA authorised Joicela on 27 May 2011
Marketing authorisation
Joicela in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Joicela approved in European Union?
Yes. EMA authorised it on 27 May 2011.
Who is the marketing authorisation holder for Joicela in European Union?
Novartis holds the EU marketing authorisation.